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Background
Affecting 1 in 500 persons, hypertrophic cardiomyopathy (HCM) is a disease or diseases characterized by marked genetic and prognostic heterogeneity [1] .
Characterized by unexplained myocardial hypertrophy in the absence of precipitating factors, HCM is the most common cause of sudden death in young athletes [1, 2] .
Since the sentinel discovery of the first locus linked to familial HCM [3] and the first HCM-associated mutations identified in the MYH7-encoded -myosin heavy chain [4] , hundreds of mutations scattered among 16 HCM-associated genes encoding sarcomeric proteins have been identified.
In a pre-genomics study by Lever et al, a striking correlation between the echocardiographically classified reverse-and sigmoidal septal contour, and age of onset was described [5] . This observation was followed by an early shape-genetic substrate analysis by Seidman et al. showing a correlation between reverse septal curvature and the presence of an HCM-associated MYH7 mutation [6] . Recently, a strong relationship between the genetic substrate comprised by all 8 myofilament genes underlying HCM and the morphological subtype was elucidated in a large cohort of genotyped patients with HCM [7] . The morphology of the left ventricle and septum were much more closely related to the presence or absence of an underlying myofilament mutation than to the age of the patient. In fact, multivariate analysis revealed reverse septal contour to be the strongest independent predictor of a myofilament mutation, with an odds ratio of 21 [7] .
Over the past several years, several studies have described sex differences in HCM [8, 9, 10, 11] . Most recently, significant sex related differences were reported in a large cohort of American and Italian patients with HCM. This study, in which women were underrepresented, showed that women were older and more symptomatic at the time of initial diagnosis [11] . Furthermore, the aforementioned study noted that women, usually with left ventricular outflow tract obstruction (LVOTO), were more likely to progress to advanced heart failure and stroke [11] . The relative contributions between sex, genetic substrate, and anatomical shape could not be ascertained because this analysis was performed on a cohort of genetically undefined and morphologically unclassified patients with HCM. Due to the heterogeneous nature both at the level of the genotype as well as the specific anatomical morphology, we sought to further evaluate the influence of sex on the HCM phenotype in a large cohort of unrelated patients with genetically and morphologically classified HCM.
Methods
Between Genomics Laboratory [12, 13, 14, 15, 16, 17, 18] . Informed consent for this IRBapproved study was obtained from all patients or parents, if underage.
Evaluation of septal curvature and cavity contour was previously performed and blinded to genotype, patients were classified morphologically into sigmoidal-, reverse curve-, apical-, and neutral contour-HCM [7] . The diagnosis of HCM was based on the echocardiographic demonstration of increased left ventricular wall thickness in the absence of clear etiology. Data on symptomatic status at initial visit (angina, dyspnea) was collected and scored in severity using the New York Heart Association (NYHA) -class, while the overall NYHA-class was assessed as well.
As hypertension is a common disease in the US population, some patients in this cohort also had mild concomitant hypertension. In these cases, the diagnosis of HCM was felt to be the appropriate diagnosis, by experienced clinicians dedicated to the care of patients with HCM, as the severity of hypertrophy was out of proportion to the concomitant hypertension. As a reference, 317 patients were referred to the Mayo HCM clinic during this time period and were felt to have either significant hypertension or aortic valve stenosis rather than HCM, and were therefore not included in this cohort.
Statistical analysis
Student's t tests and Fisher's exact tests were applied to calculate overall differences between the males and females, as well as sex differences for the four difference morphological subgroups using JMP Statistical Software (JMP 6.0, SAS Institute Inc.
2005). For characteristics with multiple levels, multivariate analyses ( 2 ) were performed to assess the distribution of the given character between sexes, and therefore a single p-value was reported. Multiple logistic and linear regression analyses which included the sex-by-shape interaction effect were used to assess whether the difference between sexes were, in fact, dependent on morphology. A pvalue <0.05 was considered statistically significant.
Results
The demographics of the entire cohort as well as the independent analysis of males and females are shown in Table 1 causes, but no sex-differences were observed in these small numbers. (14) 34 (17) 19 (11) 0.2 Hypertension (%)
52 (14) 21 (11) 31 ( To investigate the influence of septal contour, we subdivided the cohort into the four septal contour subgroups and further analyzed the sex-related based differences of the two major sub-groups of sigmoidal-and reverse curve-HCM. Strikingly, the effect of sex on clinical phenotype that was first observed for the cohort at large was present only among patients with sigmoidal-HCM ( Table 2) To assess whether the observed differences between sexes were dependent specifically on the morphology, multiple linear and logistic regression analyses were performed. For women, age at diagnosis (p = 0.01), systolic blood pressure (p = 0.008), and presence of LVOTO (p = 0.04) were in fact directly dependent on the sigmoidal morphology whereas prevalence of myectomy no longer achieved statistical significance. To investigate the potential confounding influence of concomitant hypertension, the analysis of sex-differences per septal subgroup was repeated excluding the patients diagnosed with concomitant hypertension. As shown in Table 3 , all previously observed, statistically significant differences that were confined to the sigmoidal-HCM subgroup -age at diagnosis, number of patients with obstruction, degree of LVOT obstruction and rate of surgical myectomies -persisted, and no new statistically significant differences were seen (data not shown). Again, logistic regression models showed a clear female sex-sigmoidal shape dependence with respect to age at diagnosis (p = 0.006) and presence of LVOTO (p = 0.02). Overall, patients with sigmoidal-HCM and concomitant hypertension were less likely to undergo surgical myectomy than patient without hypertension (21% vs. 52%; p < 0.001), explaining the increase of significance in surgical myectomies when hypertension was excluded from the analysis. [7] . More recently, the yield for sigmoidal-HCM increased from 8% to 14% with the inclusion of 5 Z-disc associated genes [17] . Conversely, myofilament-HCM preferentially yields reverse curve-HCM whereas Z-disc-HCM predisposes to the development of sigmoidal-HCM [20] .
Now, this present study examines the influence of sex in the interplay between genetic substrate and anatomical shape. Overall, this cohort mirrors previously published studies that examined the effect of sex on a presumably heterogeneous cohort of HCM lacking both morphological and genetic sub-classification [9, 10, 11] .
Moreover, the data presented herein suggest that the differences are largely confined to sigmoidal-HCM which constitutes the anatomical phenotype of nearly half of the patients with clinically diagnosed HCM in our institution. Furthermore, it shows that specifically for age at diagnosis, systolic blood pressure and presence of LVOTO, there is a direct sex-by-morphology interaction for women with sigmoidal-HCM.
These observations among distinct subtypes of HCM generate several questions regarding the influence of sex in the phenotypic expression of disease. More specifically, it suggests that gender does not seem to be a significant modifier in reverse curve-HCM. This is supported by our original morphological data that the underlying genotype rather than sex appears to be the predominant determinant of septal morphology [7] . Thus, in reverse curve-HCM, the presence of a structural myofilament mutation is the driver of the phenotype, whereas in sigmoidal-HCM, a multi-factorial process culminates in a clinical expression of HCM, with significant male -female differences.
The presence of mild, concomitant hypertension may be a contributing factor in the pathogenesis of sigmoidal-HCM in women as 1 of 4 females within this morphological classification of HCM were mildly hypertensive. Several studies have
shown that in response to pressure-overload, sex differences in the hypertrophic response patterns can be seen. Krumholz et al. showed that in isolated hypertension, significant sex differences can be observed in cardiac adaptation. In contrast to our findings, they show females predominantly develop a concentric hypertrophy, whereas a more eccentric pattern was observed in men [21] . Similar patterns of sex-dependent hypertrophy were observed in aortic stenosis [22, 23] and as a response to hemodynamic overload after myocardial infarction [24] . Furthermore, the presence of concomitant hypertension could mean there has always been a presence of low-grade hypertension and therefore a higher afterload in these patients. These factors combined with a (undefined) genetic susceptibility for HCM by means of a pathogenetic mutation or a LVH-promoting polymorphism [25] , or endocrine factors [26] could all converge in the phenotype of clinically diagnosed, sigmoidal-HCM.
Although recent studies have shown that the prevalence of LVOTO is far more prevalent than previously believed [27, 28] , our study may be biased with its higher prevalence of patients with obstructive HCM at rest due to our role as tertiary referral center for the surgical treatment of HCM. This is reflected in higher prevalence of patients with resting LVOTO (75% vs. ~35-40% in other published HCM cohorts) [27, 28] as well as a higher rate of surgical myectomies (42% vs. ~5-10% in other published HCM cohorts) [29] . Our observations might therefore be less applicable to a broader spectrum of patients with HCM, particularly non-obstructive HCM. On the other hand, the conclusions regarding these important sex-substrate differences appear robust for the subset of patients with obstructive disease.
Conclusions
In this large cohort of comprehensively genotyped and morphologically classified, unrelated patients with clinically diagnosed HCM, we observed that the striking and previously noted sex-related differences in HCM are confined largely to the subset of patients with mutation negative, sigmoidal-HCM. Sex does not appear to be a significant genetic modifier in myofilament-HCM.
